These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 23786280

  • 1. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
    Choi GS, Kim JH, Shin YS, Ye YM, Kim SH, Park HS.
    Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor in allergen-induced nasal inflammation.
    Choi GS, Park HJ, Hur GY, Choi SJ, Shin SY, Ye YM, Park HS.
    Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
    [Abstract] [Full Text] [Related]

  • 3. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
    Fuentes-Beltrán A, Montes-Vizuet R, Valencia-Maqueda E, Negrete-García MC, García-Cruz Mde L, Teran LM.
    Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
    [Abstract] [Full Text] [Related]

  • 4. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P, Ayuso P, Salas M, Plaza MC, Cornejo-García JA, Doña I, Torres MJ, Blanca-López N, Canto G, Guéant JL, Sanak M, Blanca M.
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [Abstract] [Full Text] [Related]

  • 5. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C, Tognella S, Visconti M, Pomari C, Trevisan F, Dal Negro RW.
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
    Trinh HKT, Pham DL, Choi Y, Kim HM, Kim SH, Park HS.
    Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease.
    Yoo HS, Shin YS, Liu JN, Kim MA, Park HS.
    Int Arch Allergy Immunol; 2013 Nov; 162(4):340-5. PubMed ID: 24193355
    [Abstract] [Full Text] [Related]

  • 9. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients.
    Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M.
    Clin Exp Allergy; 1996 Jul; 26(7):807-14. PubMed ID: 8842555
    [Abstract] [Full Text] [Related]

  • 10. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
    Stevens WW, Ocampo CJ, Berdnikovs S, Sakashita M, Mahdavinia M, Suh L, Takabayashi T, Norton JE, Hulse KE, Conley DB, Chandra RK, Tan BK, Peters AT, Grammer LC, Kato A, Harris KE, Carter RG, Fujieda S, Kern RC, Schleimer RP.
    Am J Respir Crit Care Med; 2015 Sep 15; 192(6):682-94. PubMed ID: 26067893
    [Abstract] [Full Text] [Related]

  • 11. Correlation between specific IgA and eosinophil numbers in the lavage fluid of patients with perennial allergic rhinitis.
    Oh JH, Hur GY, Ye YM, Kim JE, Park K, Park HS.
    Allergy Asthma Proc; 2008 Sep 15; 29(2):152-60. PubMed ID: 18430312
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma apolipoprotein H levels are different between aspirin induced respiratory diseases and aspirin tolerant asthma.
    Kim HJ, Park JS, Heo JS, Moon KY, Park CS.
    Pulm Pharmacol Ther; 2014 Apr 15; 27(2):184-9. PubMed ID: 24120690
    [Abstract] [Full Text] [Related]

  • 17. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R, Świerczyńska-Krępa M, Niżankowska-Mogilnicka E, Holtappels G, De Ruyck N, Sanak M, Derycke L, Van Crombruggen K, Bachert C, Pérez-Novo CA.
    Cytokine; 2016 Jan 15; 77():157-67. PubMed ID: 26615369
    [Abstract] [Full Text] [Related]

  • 18. Nasal lavage fluid and proteomics as means to identify the effects of the irritating epoxy chemical dimethylbenzylamine.
    Lindahl M, Irander K, Tagesson C, Ståhlbom B.
    Biomarkers; 2004 Jan 15; 9(1):56-70. PubMed ID: 15204311
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.